The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Audrain-McGovern, J.
* Articles by Shields, P. G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Audrain-McGovern, J.
* Articles by Shields, P. G.
Related Collections
* Nicotine
* Child/Adolescent Psychiatry
*Related Article
Am J Psychiatry 161:1224-1230, July 2004
© 2004 American Psychiatric Association


Article

Interacting Effects of Genetic Predisposition and Depression on Adolescent Smoking Progression

Janet Audrain-McGovern, Ph.D., Caryn Lerman, Ph.D., E. Paul Wileyto, Ph.D., Daniel Rodriguez, Ph.D., and Peter G. Shields, M.D.

OBJECTIVE: The goal of the present study was to identify specific genetic associations with smoking progression in adolescents and to determine whether these genetic effects on smoking practices are potentiated by depression symptoms. METHOD: Effects of dopamine transporter (SLC6A3) and dopamine receptor (DRD2) genetic variants on smoking progression were evaluated in a cohort of 615 adolescents, including those who had never smoked, and in a subgroup including only adolescents who had been exposed to nicotine (i.e., smoked at least a puff of a cigarette) (N=292). These adolescents were followed from 9th to 11th grade. Depression symptoms were also assessed. RESULTS: In the model of adolescents with a previous smoking experience, the likelihood of progressing to a higher level of smoking by the 11th grade increased almost twofold with each additional DRD2 A1 allele. The likelihood of smoking progression with each additional A1 allele was more pronounced among adolescents with substantial depression symptoms. The model including never-smokers revealed no significant genetic effects. Neither model revealed effects of SLC6A3. CONCLUSIONS: These results provide the first evidence, to the authors’ knowledge, for an association of the DRD2 A1 allele with smoking progression among adolescents. This effect is potentiated by depression symptoms. These effects appear to be specific to adolescents who have had at least some nicotine exposure (i.e., at least a puff of a cigarette).


Related Article:

In This Issue
Am J Psychiatry 2004 161: A74. [Full Text] [PDF]



This article has been cited by other articles:


Home page
JAMAHome page
S. A. Schroeder
A 51-Year-Old Woman With Bipolar Disorder Who Wants to Quit Smoking
JAMA, February 4, 2009; 301(5): 522 - 531.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
C T C Okoli, C G Richardson, P A Ratner, and J L Johnson
An examination of the smoking identities and taxonomies of smoking behaviour of youth
Tob. Control, June 1, 2008; 17(3): 151 - 158.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. A. Johnson, S. Cen, P. Gallaher, P. H. Palmer, L. Xiao, A. Ritt-Olson, and J. B. Unger
Why Smoking Prevention Programs Sometimes Fail. Does Effectiveness Depend on Sociocultural Context and Individual Characteristics?
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1043 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
U. W. Preuss, P. Zill, G. Koller, B. Bondy, and M. Soyka
D2 dopamine receptor gene haplotypes and their influence on alcohol and tobacco consumption magnitude in alcohol-dependent individuals
Alcohol Alcohol., May 1, 2007; 42(3): 258 - 266.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. L. Brody, M. A. Mandelkern, R. E. Olmstead, D. Scheibal, E. Hahn, S. Shiraga, E. Zamora-Paja, J. Farahi, S. Saxena, E. D. London, et al.
Gene Variants of Brain Dopamine Pathways and Smoking-Induced Dopamine Release in the Ventral Caudate/Nucleus Accumbens.
Arch Gen Psychiatry, July 1, 2006; 63(7): 808 - 816.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. M. Lee and R. F. Tyndale
Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment
J Psychopharmacol, July 1, 2006; 20(4_suppl): 7 - 14.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. Audrain-McGovern, D. Rodriguez, E. P. Wileyto, K. H. Schmitz, and P. G. Shields
Effect of team sport participation on genetic predisposition to adolescent smoking progression.
Arch Gen Psychiatry, April 1, 2006; 63(4): 433 - 441.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
O. Klungsoyr, J. F. Nygard, T. Sorensen, and I. Sandanger
Cigarette Smoking and Incidence of First Depressive Episode: An 11-Year, Population-based Follow-up Study
Am. J. Epidemiol., March 1, 2006; 163(5): 421 - 432.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org